Invention Grant
US08378097B2 3-(1,3-benzodioxol-5-yl)-6-(4-cyclopropylpiperazin-1-yl)-pyridazine, its salts and solvates and its use as histamine H3 receptor antagonist
有权
3-（1,3-苯并间二氧杂环戊烯-5-基）-6-（4-环丙基哌嗪-1-基） - 哒嗪及其盐和溶剂合物及其作为组胺H3受体拮抗剂
- Patent Title: 3-(1,3-benzodioxol-5-yl)-6-(4-cyclopropylpiperazin-1-yl)-pyridazine, its salts and solvates and its use as histamine H3 receptor antagonist
- Patent Title (中): 3-（1,3-苯并间二氧杂环戊烯-5-基）-6-（4-环丙基哌嗪-1-基） - 哒嗪及其盐和溶剂合物及其作为组胺H3受体拮抗剂
-
Application No.: US12302132Application Date: 2007-05-22
-
Publication No.: US08378097B2Publication Date: 2013-02-19
- Inventor: Rolf Hohlweg
- Applicant: Rolf Hohlweg
- Applicant Address: US NC High Point
- Assignee: High Point Pharmaceuticals, LLC
- Current Assignee: High Point Pharmaceuticals, LLC
- Current Assignee Address: US NC High Point
- Agent Samuel B. Rollins
- Priority: EP06114615 20060529; EP06120117 20060905
- International Application: PCT/EP2007/054940 WO 20070522
- International Announcement: WO2007/137968 WO 20071206
- Main IPC: C07D237/02
- IPC: C07D237/02 ; A61K31/50
Abstract:
3-(1,3-Benzodioxol-5-yl)-6-(4-cyclopropylpiperazin-1-yl)pyridazine and salts and solvates thereof, having histamine H3 antagonistic activity can be used in pharmaceutical compositions.
Public/Granted literature
Information query
